Introduction {#sec1}
============

The antitumor activity of neutral dirhodium(II) complexes with bridging carboxylate groups in a cage structure, Rh~2~(μ-RCOO)~4~ (R = CH~3~, C~2~H~5~, and C~3~H~7~), was initially reported in 1972 by Bear and co-workers.^[@ref1]−[@ref3]^ They observed that the survival time of mice bearing Ehrlich ascites or leukemia L1210 tumors increased when they were treated with dirhodium(II) carboxylates. The treatment was also effective against leukemia P388 and sarcoma 180 tumors. This class of compounds could inhibit in vivo DNA synthesis of Ehrlich ascites tumor cells, and in vitro DNA and RNA polymerase from *Escherichia coli*.^[@ref4]−[@ref6]^ The metabolism of dirhodium(II) tetraacetate was explored by injecting ^14^C-labeled Rh~2~(AcO)~4~ in tumor-bearing Swiss mice, which exhaled ^14^CO~2~ within 2 h after injection, indicating breakdown of the cage structure into carboxylate and rhodium ions. The rhodium was mainly deposited in the liver, with only ∼5% excreted through urine within the first 24 h after administrating the drug.^[@ref7]^ A similar structural breakdown was observed when reacting dirhodium(II) tetraacetate (**1**, Rh~2~(AcO)~4~) with cysteine in the mole ratio 1:4 at pH = 7.5, which resulted in an insoluble Rh(III)--cysteine complex, protons, and free acetate groups.^[@ref7],[@ref8]^ In vitro studies showed that human serum albumin maintained the cage structure of Rh~2~(AcO)~4~ by binding to its axial positions via the *N*-imidazole moieties of its histidine residues.^[@ref9]^ Although enzymes containing thiol (−SH) groups at or near their active site were irreversibly inhibited by dirhodium(II) carboxylates, other enzymes without free −SH groups, or those containing thiol groups away from their active site, were not affected.^[@ref8],[@ref10]^ Inhibition was proposed to involve reactions of protein--thiol groups with dirhodium(II) carboxylates, leading to breakdown of their cage structure, oxidation of Rh(II), and tight binding of Rh(III) ions to the active site of those enzymes. The results were then correlated to the limited excretion of rhodium from mice treated with dirhodium(II) tetraacetate, indicating that rhodium probably binds to thiol-containing proteins at the cell membrane.^[@ref7],[@ref8]^ Bear et al. suggested that the antitumor efficiency of this class of dirhodium(II) carboxylate compounds could be enhanced by increasing their resistance toward reaction with −SH groups, for example, by blocking the axial positions (assumed as the initial −SH coordination sites) with stronger ligands such as polyadenylic acid.^[@ref11]^ They also proposed that as a detoxification step after administering a large dose of a dirhodium(II) carboxylate drug, treatment with a nontoxic thiol-containing molecule such as glutathione should be considered.^[@ref11]^

In 1980, Pneumatikakis and Psaroulis reported the reactions of \[Rh~2~(AcO)~4~(CH~3~OH)~2~\] with cysteine, penicillamine, or cysteine methylester (1:4 mole ratio), which produced precipitates characterized as mononuclear paramagnetic square-planar Rh(II) complexes with (S,N)-coordinated ligands.^[@ref12]^

Two decades later, the reactions of \[Rh~2~(AcO)~2~(N--N)~2~(CH~3~CN)~2~\]X~2~ {N--N = 1,10-phenantroline (phen) or 2,2′-bipyridine (bpy), **2**; X = PF~6~ or BF~4~, respectively}, among other Rh complexes,^[@ref13]^ were investigated with 2-aminothiophenol (at mole ratios of 1:10 and 1:4) under aerobic conditions as models for how antitumor active dirhodium(II) bis-polypyridine compounds react with thiol-containing biomolecules. Reaction products included mononuclear \[Rh^III^(*S*,*N*-C~6~H~6~NS)(*S*-C~6~H~6~NS)~2~(phen)\] or binuclear \[Rh^III^(μ-*S*,*N*-C~6~H~6~NS)(η^1^-*S*-C~6~H~6~NS)(bpy)\]~2~^2+^ (**3a**) with mononuclear \[Rh^III^(*S*,*N*-C~6~H~6~NS)~2~(bpy)\]^+^ (**3b**) cocrystallized in the same unit cell ([Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}).^[@ref14]^ With excess sodium benzene-thiolate (Na^+^C~6~H~5~S^--^) in dry degassed methanol, the bipyridine complex **2** generated the dark red binuclear \[Rh^II^(μ-*S*-C~6~H~5~S)(η^1^-*S*-C~6~H~5~S)(bpy)\]~2~·CH~3~OH crystalline complex (**3′**) with two bridging and two terminal thiolates.^[@ref15]^ This complex was considered as a model for a reactive intermediate that, in the presence of oxygen, could produce Rh(III) species that were similar to those formed with 2-aminothiophenol.^[@ref14]^ Dark blue precipitates were obtained by reacting **2** with cysteine and glutathione (at a mole ratio of 1:4) under anaerobic conditions, but these were not structurally characterized.^[@ref15]^

![Structures of \[Rh^II^~2~(AcO)~4~\] (**1**), \[Rh^II^~2~(AcO)~2~(bpy)~2~(CH~3~CN)~2~\]^2+^ (**2**), and Its Reaction Products with Thiolates: \[Rh^II^(μ-*S*-C~6~H~5~S)(η^1^-*S*-C~6~H~5~S)(bpy)\]~2~ (**3′**), \[Rh^III^(μ-*S*,*N*-C~6~H~6~NS)(η^1^-*S*-C~6~H~6~NS)(bpy)\]~2~^2+^ (**3a**), and \[Rh^III^(*S*,*N*-C~6~H~6~NS)~2~(bpy)\]^+^ (**3b**) Reported in Refs ([@ref13]−[@ref15])](ao-2017-01090p_0006){#sch1}

Here, we report the results of our characterization of the reaction products from Rh~2~(AcO)~4~ (**1**) and the thiol-containing amino acids [l]{.smallcaps}-cysteine (H~2~Cys), [d]{.smallcaps}-penicillamine (3,3′-dimethylcysteine, H~2~Pen), and *N*-acetyl-[l]{.smallcaps}-cysteine (H~2~NAC), using electrospray ionization mass spectrometry (ESI-MS), solid state carbon-13 cross polarization magic angle spinning (CPMAS) NMR, and X-ray absorption spectroscopy (XAS). The choice of these biologically relevant ligands was based on their potential to form S,N-chelates (H~2~Cys and H~2~Pen), or to act solely as a monodentate thiol ligand (H~2~NAC). Moreover, penicillamine probes the influence of increased steric hindrance in the vicinity of the thiol group. The results reveal the nature and structure of the decomposition products that were previously reported but not identified,^[@ref7],[@ref8]^ and increase our understanding of the fate of dirhodium(II) carboxylates in vivo in the presence of thiol-containing proteins and enzymes.

Experimental Section {#sec2}
====================

Sample Preparation {#sec2.1}
------------------

[l]{.smallcaps}-Cysteine, [d]{.smallcaps}-penicillamine, *N*-acetyl-[l]{.smallcaps}-cysteine, and sodium hydroxide were purchased from Sigma-Aldrich, and dirhodium(II) tetraacetate (pure; 47% Rh) was obtained from Pressure Chemical Company; all were used without further purification. Degassed water and D~2~O were prepared by bubbling argon through boiled distilled water or D~2~O for 3 h until they had cooled down to room temperature. Sephadex G-15 was obtained from VWR International.

A calibrated Thermo Scientific Orion Star semi-micro electrode was used for pH measurements. Thermogravimetry (TG), to measure water content, was carried out using a Netzsch STA 409 instrument, and a Johnson Matthey magnetic susceptibility balance was used to analyze the magnetic properties of the solid samples.

Solid {Rh~2~^III^(HCys)~2~(Cys)~2~·4H~2~O}*~n~* (**4**) {#sec2.2}
-------------------------------------------------------

To a completely dissolved solution of dirhodium(II) tetraacetate (0.1123 g, 0.254 mmol) in 40 mL of oxygen-free water, solid cysteine (0.1234 g, 1.018 mmol) was added under a stream of argon to prevent oxidation of the ligand to cystine. The solution color gradually changed from emerald green to orange-brown and a precipitate was formed (pH = 3.2). The mixture was stirred for 24 h at room temperature under aerobic conditions. The precipitate was filtered, washed with methanol and ether several times and dried under vacuum in a desiccator. Elemental analysis: calcd for {Rh~2~^III^(HCys)~2~(Cys)~2~·4H~2~O}~*n*~, (Rh~2~C~12~H~30~O~12~S~4~N~4~): %C 19.05, %H 4.00, %N 7.41 (9.5% H~2~O); found: %C 19.30, %H 4.06, %N 6.86 (TG: 9.9% H~2~O); yield = 91%. Magnetic susceptibility measurements showed the solid bulk, which is insoluble in solvents, to be diamagnetic.

Aerobic Reaction of Rh~2~(AcO)~4~ with Thiol-Containing Ligands H~2~L (pH = 7.4) {#sec2.3}
--------------------------------------------------------------------------------

An emerald green suspension of 0.100 g (0.226 mmol) of dirhodium(II) tetraacetate in 30 mL of degassed water was added dropwise to colorless solutions containing one of the following H~2~L ligands (0.909 mmol of H~2~Cys, or 0.905 mmol of H~2~Pen, or 0.906 mmol of H~2~NAC) dissolved in 90 mL of degassed water. The reactions were carried out under a stream of argon to prevent formation of disulfides by oxidation of the ligand −SH group. When adding 1.0 M NaOH dropwise to adjust the pH of the solutions to 7.4, their color turned to dark red/orange. The reaction mixtures were stirred at room temperature (RT) for 2 h under argon flow, and then exposed to air for another 46 h, while regularly adjusting the pH by adding 1.0 M NaOH. ESI-mass spectra were measured at different time intervals (30 min, 2 h, 24 h, and 48 h after pH adjustment). A rotary evaporator was used (at RT) to reduce the volume before passing the solution through a Sephadex G-15 size exclusion chromatography column with water as eluent. ESI-mass spectra were measured for different parts of the orange band, which was separated and concentrated. A portion of the concentrated solution was set aside for extended X-ray absorption fine structure (EXAFS) spectroscopic measurement, and the remaining part was evaporated to dryness and further dried in a desiccator under vacuum. Elemental analyses of the solid products from the three reactions are as follows:

Calcd for {Na~2~\[Rh~2~(Cys)~4~\]·5H~2~O}~*n*~ (Rh~2~C~12~H~30~N~4~O~13~S~4~Na~2~) (**5**): %C 17.61, %H 3.69, %N 6.85 (11.00% H~2~O); found: %C 17.93, %H 3.69, %N 6.82 (TG: 10.57% H~2~O); yield = 72%. Calcd for Na~2~\[Rh~2~(Pen)~2~(Pen(SO))~2~\]·4.5H~2~O (Rh~2~C~20~H~45~N~4~O~14.5~S~4~Na~2~) (**6**): %C 25.19, %H 4.76, %N 5.87 (8.50% H~2~O); found: %C 25.22, %H 4.72, %N 5.76 (TG: 8.12% H~2~O); yield = 67%. Calcd for {Na~2~\[Rh~2~(NAC)~4~\]·4.5H~2~O}~*n*~ (Rh~2~C~20~H~37~N~4~O~16.5~S~4~Na~2~) (**7**): %C 24.57, %H 3.81, %N 5.73 (8.29% H~2~O); found: %C 24.21, %H 3.41, %N 5.45 (TG: 7.99% H~2~O); yield = 76%.

These solid samples, which were all diamagnetic and water soluble (only partially soluble in dimethyl sulfoxide and insoluble in other common solvents), were used for ^13^C CPMAS NMR, ESI-MS, electron paramagnetic resonance (EPR), Rh K edge EXAFS, and S K edge X-ray absorption near-edge structure (XANES) spectroscopic measurements.

NMR Spectroscopy {#sec2.4}
----------------

Carbon-13 cross-polarization magic angle spinning (CPMAS) NMR spectra were measured for solid compounds at room temperature using a Bruker Avance 500 MHz spectrometer with high power proton decoupling, setting α-glycine carbonyl at 176.50 ppm as reference.^[@ref16]^ The ground solids **1**, **4**--**7**, and the H~2~L compounds used as ligands were packed separately into a 4 mm zirconia rotor spinning at an magic angle spinning rate of 12 kHz, collecting ∼100 scans with a 10 s recycle delay for each sample.

ESI-Mass Spectrometry {#sec2.5}
---------------------

An Agilent 6520 Q-ToF instrument was used to measure ESI-mass spectra both in positive (+) and negative (−) ion modes. Voltages for capillary, skimmer, and fragmentor were set at 4000, 65, and 80 V, respectively. Solid samples were dissolved in water, and methanol was used as the mobile phase with a continuous injection flow rate of 0.2 mL min^--1^ and a drying gas flow rate of 7 L min^--1^ at 200 °C. For voltage variable measurements, the fragmentor voltage varied between 0 and 80 V. The nature of the mass ions and their corresponding *m*/*z* values were confirmed using the isotope distribution calculator from Agilent, and a high resolution calculation method chosen from Scientific Instrument Services (SIS).^[@ref17]^

Electronic Spectroscopy {#sec2.6}
-----------------------

UV--vis absorption spectra were measured at RT using a Cary 300 UV--vis double-beam spectrophotometer. Samples were measured in quartz cells with 1 mm path-length, using water in the reference position.

X-ray Absorption Spectroscopy Data Collection {#sec2.7}
---------------------------------------------

Rh K edge EXAFS spectra of the solid {Rh~2~^III^(Cys)~2~(HCys)~2~·4H~2~O}~*n*~ (**4**) precipitated at pH = 3.2, the concentrated solutions (pH = 7.4), and corresponding solid compounds {Na~2~\[Rh~2~(Cys)~4~\]·5H~2~O}~*n*~ (**5**), Na~2~\[Rh~2~(Pen)~2~(Pen(SO))~2~\]·4.5H~2~O (**6**), and {Na~2~\[Rh~2~(NAC)~4~\]·4.5H~2~O}~*n*~ (**7**) were measured at room temperature at BL 7--3 (500 mA) at the Stanford Synchrotron Radiation Lightsource (SSRL) operating under 3 GeV. Higher-order harmonics were rejected by detuning the Si(220) (ϕ = 0°) double-crystal monochromator to 50% of maximum intensity at the end of the Rh K edge scan range. The X-ray energy was internally calibrated by assigning the first inflection point of the absorption edge of a Rh foil placed between the ion chambers I~1~ and I~2~ to 23 219.80 eV. Three ion chambers (I~0~, I~1~, and I~2~) were filled with nitrogen (N~2~). Four to ten scans were collected for each sample in transmission mode and compared prior to averaging to ensure that no radiation damage occurred during measurement.

S K edge XANES spectra of the solid compounds **5**--**7** were measured at BL 4--3 (SSRL), equipped with a Si(111) double-crystal monochromator, a harmonic rejection mirror, and a Vortex fluorescence detector. The solid samples were finely ground, dusted on Mylar tape, and placed in a sample chamber filled with helium. Two scans collected in fluorescence mode were averaged. Energy calibration was achieved by setting the first peak maximum in the S XANES spectrum of Na~2~S~2~O~3~·5H~2~O to 2472.02 eV.

XAS Data Analysis {#sec2.8}
-----------------

The WinXAS 3.1 program^[@ref18]^ was used for first order polynominal pre-edge background subtraction and normalization of the Rh K edge XAS spectra, followed by subtraction of a seven segment cubic spline in the post-edge region to extract the EXAFS oscillations. The first inflection point of the absorption edges varied over a narrow range (*E*~0~ = 23 226.3--23 226.7 eV). To simulate theoretical EXAFS oscillations, the atomic coordinates of ΔΛ-\[Rh{Ir(aet)~3~}~2~\]^3+^ (Haet = 2-aminoethanethiol) with the Cambridge Structural Database (CSD) code AQUVOX,^[@ref19]^ were used for the ATOMS and Feff 7.0 programs,^[@ref20],[@ref21]^ replacing Ir with Rh, as the ionic radii of Rh^3+^ and Ir^3+^ ions are very similar (0.665 and 0.68 Å, respectively).^[@ref22]^

Least-squares curve-fitting of the theoretically simulated EXAFS oscillations to the experimental EXAFS spectra was performed over the *k*-range ∼2.8--18.2 Å^--1^. The wide *k*-range EXAFS data of good quality allowed simultaneous refinement of the coordination numbers (CN), bond distances (*R*), and the Debye--Waller factor parameters (σ^2^), unless otherwise stated. The Δ*E*~0~ was allowed to float as a common value for all scattering paths involved in the fitting. The amplitude reduction factor (*S*~0~^2^) was set at 0.92, as obtained from the EXAFS data analysis of solid Rh~2~(AcO)~4~.^[@ref23]^ The accuracy of the bond distances, σ^2^ (mean square of the variation around the mean distance), and refined CN values is within ±0.02 Å, ±0.001 Å^2^, and ±10--15%, respectively. The residual () from the least-squares curve-fitting in *k*-space is defined aswhere *y*~exp~ and *y*~theo~ denote experimental and theoretical data points, respectively.

Results {#sec3}
=======

Dirhodium(II) tetraacetate, Rh~2~(AcO)~4~ (**1**), has limited solubility in water. When a completely dissolved aqueous solution of **1** (emerald green) is mixed with a fourfold amount of cysteine under aerobic conditions, a red-brown precipitate is formed after 5 min (pH = 3.2), whereas similar reactions with *N*-acetylcysteine or penicillamine result in clear emerald green solutions. When adjusting the pH to 7.4, the reactions proceed quickly with a color change to orange-red (see [Experimental Section](#sec2){ref-type="other"}). To monitor the early stages of the reaction for the solutions containing *N*-acetylcysteine or penicillamine, we measured, over a period of time, their ESI-MS, UV--vis, and/or ^1^H NMR spectra at the pH of mixing (acidic) at which the reaction is relatively slow. The majority of these results are presented in [Appendices 1 and 2](http://pubs.acs.org/doi/suppl/10.1021/acsomega.7b01090/suppl_file/ao7b01090_si_001.pdf) in the [Supporting Information](http://pubs.acs.org/doi/suppl/10.1021/acsomega.7b01090/suppl_file/ao7b01090_si_001.pdf) ([Figures S-1--S-5, Tables S-1, and S-2](http://pubs.acs.org/doi/suppl/10.1021/acsomega.7b01090/suppl_file/ao7b01090_si_001.pdf)), including the ESI-mass spectra of pure Rh~2~(AcO)~4~ in water ([Figure S-6](http://pubs.acs.org/doi/suppl/10.1021/acsomega.7b01090/suppl_file/ao7b01090_si_001.pdf)).

The UV--vis spectrum of a solution containing Rh~2~(AcO)~4~ and H~2~NAC (*C*~**1**~ = 1.0 mM, mole ratio of 1:4) at the pH of mixing (2.8) initially displayed a broad peak around 340 nm, which gradually red-shifted with time while gaining intensity, with its highest intensity at λ~max~ = 367 nm observed after 48 h (see [Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}, left). ESI-mass spectra of the same UV--vis samples showed peaks associated with \[Rh~2~^III^(AcO)~4~(HNAC)~2~ ± H^+^\]^+/--^ (*m*/*z* = 764.90 and 766.91) and the corresponding Na^+^ mass ions (+*m*/*z* = 788.90 and 810.88) as well as intense peaks assigned to unreacted Rh~2~(AcO)~4~ (+*m*/*z* = 459.90, 464.85, and 505.88); see [Figures [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"} (right) and [S-3](http://pubs.acs.org/doi/suppl/10.1021/acsomega.7b01090/suppl_file/ao7b01090_si_001.pdf), and [Tables [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"} and [S-1](http://pubs.acs.org/doi/suppl/10.1021/acsomega.7b01090/suppl_file/ao7b01090_si_001.pdf). No mass peak was related to the mononuclear Rh(III) complex. When the pH of the solution mixture was adjusted to 7.4 after 48 h, the peak intensity at λ~max~ = 367 nm substantially decreased within a few minutes. This peak does not appear in the UV--vis spectra when adjusting the reaction pH to 7.4 directly after mixing the reactants (see [Figure S-7](http://pubs.acs.org/doi/suppl/10.1021/acsomega.7b01090/suppl_file/ao7b01090_si_001.pdf)).

![(Left) UV--vis spectroscopy of reaction progress for Rh~2~(AcO)~4~ with H~2~NAC (mole ratio of 1:4, *C*~**1**~ = 1.0 mM, pH of mixing = 2.8); peak positions are obtained from second derivatives. (Right) ESI-mass spectrum (+ ion mode) of the same solution measured after 48 h; see [Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"} for peak assignments.](ao-2017-01090p_0001){#fig1}

###### Assignment of the ESI-MS Peaks Shown in [Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"} (Right)[a](#t1fn1){ref-type="table-fn"}

  *m*/*z* (M)   isotopic pattern   assignment                                    *m*/*z* (M)   isotopic pattern   assignment
  ------------- ------------------ --------------------------------------------- ------------- ------------------ --------------------------------------------------------
  186.02        M + 1              \[H~2~NAC + Na^+^\]^+^                        627.88        M + 1              \[2Rh^II^ + 4AcO^--^ + H~2~NAC + Na^+^\]^+^
  325.05        M + 1              \[2H~2~NAC -- 2H^+^ + H^+^\]^+^               671.08        M + 1              \[4H~2~NAC -- 4H^+^ + Na^+^\]^+^
  347.03        M + 1              \[2H~2~NAC -- 2H^+^ + Na^+^\]^+^              766.91        M + 1              \[2Rh^III^ + 4AcO^--^ + 2HNAC^--^ + H^+^\]^+^
  459.90        M + 1              \[2Rh^II^ + 4AcO^--^ + NH~4~^+^\]^+^          788.90        M + 1              \[2Rh^III^ + 4AcO^--^ + 2HNAC^--^ + Na^+^\]^+^
  464.85        M + 1              \[2Rh^II^ + 4AcO^--^ + Na^+^\]^+^             810.88        M + 1              \[2Rh^III^ + 4AcO^--^ + 2HNAC^--^ -- H^+^ +2Na^+^\]^+^
  505.88        M + 1              \[2Rh^II^ + 4AcO^--^ + CH~3~CN + Na^+^\]^+^                                     

H~2~NAC = C~5~H~9~NO~3~S; 2H~2~NAC -- 2H^+^ is the oxidized form of *N*-acetylcysteine with an S--S bond; AcO^--^ = CH~3~COO^--^.

Reaction of Rh~2~(AcO)~4~ with Thiols at Physiological pH {#sec3.1}
---------------------------------------------------------

The results presented below refer to the aerobic reactions of Rh~2~(AcO)~4~ with thiol-containing ligands (H~2~L) in the mole ratio of 1:4. Other mole ratios (1:2 and 1:6) led to the same products (**5**--**7**) in different yields (44--49 and 77--96% for mole ratios of 1:2 and 1:6, respectively); see [Appendix 3](http://pubs.acs.org/doi/suppl/10.1021/acsomega.7b01090/suppl_file/ao7b01090_si_001.pdf) in the [Supporting Information](http://pubs.acs.org/doi/suppl/10.1021/acsomega.7b01090/suppl_file/ao7b01090_si_001.pdf), where an image of the size exclusion chromatography purification column is shown for a solution containing Rh~2~(OAc)~4~ and H~2~NAC (mole ratio of 1:4).

### ESI-Mass Spectrometry {#sec3.1.1}

The most intense peaks in the ESI-mass spectra (− ion mode, fragmentor voltage 80 V) of the products obtained from the reactions of **1** with cysteine (**5**), penicillamine (**6**), or *N*-acetylcysteine (**7**) at pH = 7.4 were associated with \[Rh^III^~2~L~4~\]^2--^ ions that had satellite peaks with (−)*m*/*z* +8 and +16; see [Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"} and [Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}. In all mass ions, the oxidation state of the rhodium ions is +3, except for \[Rh^II^~2~(NAC)~3~\]^2--^ (−*m*/*z* = 344.43). On the basis of the observed isotopic patterns, tri-, tetra-, or hexanuclear mass ions were also detected, but no mononuclear rhodium mass ion was observed in the spectra shown in [Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}. ESI-mass spectra of reaction mixtures with Rh~2~(AcO)~4~/H~2~L in a mole ratio of 1:2 showed the same mass ions, together with large peaks related to unreacted Rh~2~(AcO)~4~ (see [Appendix 3](http://pubs.acs.org/doi/suppl/10.1021/acsomega.7b01090/suppl_file/ao7b01090_si_001.pdf) in the [Supporting Information](http://pubs.acs.org/doi/suppl/10.1021/acsomega.7b01090/suppl_file/ao7b01090_si_001.pdf) for H~2~Pen reaction).

![ESI-mass spectra (− ion mode) of the products (in water) obtained from the reactions of Rh~2~(AcO)~4~ with cysteine (**5**, top), penicillamine (**6**, middle), and *N*-acetylcysteine (**7**, bottom) at a mole ratio of 1:4 at pH = 7.4 (fragmentor voltage 80 V). For peak assignments, see [Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}.](ao-2017-01090p_0002){#fig2}

###### Assignment of the Mass Ions Observed in the ESI-Mass Spectra (− Ion Mode) of Products **5**--**7** Shown in [Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}[a](#t2fn1){ref-type="table-fn"}

  *m*/*z* (M)                              isotopic pattern                          assignment                                            *m*/*z* (M)                                        isotopic pattern                                  assignment
  ---------------------------------------- ----------------------------------------- ----------------------------------------------------- -------------------------------------------------- ------------------------------------------------- ------------------------------------------------
  Rh--Cysteine Product (**5**)                                                                                                                                                                                                                  
  340.91                                   M + 0.5                                   \[2Rh^III^ + 4H~2~Cys -- 8H^+^\]^2--^                 511.87                                             M + 0.5                                           \[3Rh^III^ + 6H~2~Cys -- 11H^+^\]^2--^
  M + 0.33                                 \[3Rh^III^ + 6H~2~Cys -- 12H^+^\]^3--^    519.87                                                M + 0.5                                            \[3Rh^III^ + 6H~2~Cys -- 11H^+^ + O\]^2--^        
  348.91                                   M + 0.5                                   \[2Rh^III^ + 4H~2~Cys -- 8H^+^ + O\]^2--^             682.83                                             M + 0.5                                           \[4Rh^III^ + 8H~2~Cys -- 14H^+^\]^2--^
  356.91                                   M + 0.5                                   \[2Rh^III^ + 4H~2~Cys -- 8H^+^ + 2O\]^2--^            M + 1                                              \[2Rh^III^ + 4H~2~Cys -- 7H^+^\]^−^               
  409.42                                   M + 0.5                                   \[2Rh^III^ + 5H~2~Cys -- 8H^+^ + O\]^2−^              690.83                                             M + 0.5                                           \[4Rh^III^ + 8H~2~Cys -- 14H^+^ + O\]^2--^
  417.42                                   M + 0.5                                   \[2Rh^III^ + 5H~2~Cys -- 8H^+^ + 2O\]^2--^            698.83                                             M + 0.5                                           \[4Rh^III^ + 8H~2~Cys -- 14H^+^ + 2O\]^2--^
  454.89                                   M + 0.33                                  \[4Rh^III^ + 8H~2~Cys -- 15H^+^\]^3--^                M + 1                                              \[2Rh^III^ + 4H~2~Cys -- 7H^+^ + O\]^−^           
  Rh--Penicillamine Product (**6**)                                                                                                                                                                                                             
  339.44                                   M + 0.5                                   \[2Rh^III^ +3H~2~Pen + S^2--^ -- 6H^+^\]^2--^         794.96                                             M + 0.5                                           \[4Rh^III^ + 8H~2~Pen -- 14H^+^\]^2--^
  347.44                                   M + 0.5                                   \[2Rh^III^ + 3H~2~Pen + S^2--^ -- 6H^+^ + O\]^2--^    M + 1                                              \[2Rh^III^ + 4H~2~Pen -- 7H^+^\]^−^               
  355.44                                   M + 0.5                                   \[2Rh^III^ + 3H~2~Pen + S^2--^ -- 6H^+^ + 2O\]^2--^   810.95                                             M + 0.5                                           \[4Rh^III^ + 8H~2~Pen -- 14H^+^ + O\]^2--^
  396.98                                   M + 0.5                                   \[2Rh^III^ + 4H~2~Pen -- 8H^+^\]^2--^                 M + 1                                              \[2Rh^III^ + 4H~2~Pen -- 7H^+^ + O\]^−^           
  404.97                                   M + 0.5                                   \[2Rh^III^ + 4H~2~Pen -- 8H^+^ + O\]^2--^             816.94                                             M + 1                                             \[2Rh^III^ + 4H~2~Pen -- 8H^+^ + Na^+^\]^−^
  412.97                                   M + 0.5                                   \[2Rh^III^ + 4H~2~Pen -- 8H^+^ + 2O\]^2--^            826.95                                             M + 1                                             \[2Rh^III^ + 4H~2~Pen -- 7H^+^ + 2O\]^−^
  Rh--*N*-acetylcysteine Product (**7**)                                                                                                                                                                                                        
  323.04                                   M + 1                                     \[2H~2~NAC -- 3H^+^\]^−^                              637.91                                             M + 0.5                                           \[3Rh^III^ + 6H~2~NAC -- 11H^+^\]^2--^
  344.43                                   M + 0.5                                   \[2Rh^II^ + 3H~2~NAC -- 6H^+^\]^2--^                  M + 0.25                                           \[6Rh^III^ + 12H~2~NAC -- 22H^+^\]^4--^           
  424.93                                   M + 0.5                                   \[2Rh^III^ + 4H~2~NAC -- 8H^+^\]^2--^                 648.90                                             M + 0.5                                           \[3Rh^III^ + 6H~2~NAC -- 12H^+^ + Na^+^\]^2--^
  M + 0.33                                 \[3Rh^III^ + 6H~2~NAC -- 12H^+^\]^3--^    M + 0.25                                              \[6Rh^III^ + 12H~2~NAC -- 24H^+^ + 2Na^+^\]^4--^                                                     
  432.93                                   M + 0.5                                   \[2Rh^III^ + 4H~2~NAC -- 8H^+^ + O\]^2--^             850.87                                             M + 1                                             \[2Rh^III^ + 4H~2~NAC -- 7H^+^\]^−^
  506.45                                   M + 0.25                                  \[2Rh^III^ + 5H~2~NAC -- 10H^+^\]^4--^                M + 0.5                                            \[4Rh^III^ + 8H~2~NAC -- 14H^+^\]^2--^            
  512.57                                   M + 0.33                                  \[4Rh^III^ + 7H~2~NAC -- 15H^+^\]^3--^                M + 0.33                                           \[6Rh^III^ + 12H~2~NAC -- 21H^+^\]^3--^           
  556.39                                   M + 0.5                                   \[3Rh^III^ + 5H~2~NAC -- 11H^+^\]^2--^                861.87                                             M + 0.5                                           \[4Rh^III^ + 8H~2~NAC -- 15H^+^ + Na^+^\]^2--^
  M + 0.25                                 \[6Rh^III^ + 10H~2~NAC -- 22H^+^\]^4--^   872.86                                                M + 1                                              \[2Rh^III^ + 4H~2~NAC -- 8H^+^ + Na^+^\]^−^       
  566.92                                   M + 0.33                                  \[4Rh^III^ + 8H~2~NAC -- 15H^+^\]^3--^                M + 0.5                                            \[4Rh^III^ + 8H~2~NAC -- 16H^+^ + 2Na^+^\]^2--^   
  621.26                                   M + 0.33                                  \[4Rh^III^ + 9H~2~NAC -- 15H^+^\]^3--^                M + 0.33                                           \[6Rh^III^ + 12H~2~NAC −24H^+^ + 3Na^+^\]^3--^    

H~2~Cys = C~3~H~7~NO~2~S; H~2~Pen = C~5~H~11~NO~2~S; H~2~NAC = C~5~H~9~NO~3~S; 2H~2~NAC -- 2H^+^ is the oxidized form of *N*-acetylcysteine with a S--S bond.

When setting the fragmentor voltage at 0 V, the main mass peaks observed for the Rh--penicillamine reaction product **6** were those of \[Rh^III^~2~(Pen)~4~ + H^+^\]^−^ (−*m*/*z* = 794.96), \[Rh^III^~2~(Pen)~4~ + H^+^ + O\]^−^ (−*m*/*z* = 810.95), and \[Rh^III^~2~(Pen)~4~ + H^+^ + 2O\]^−^ (−*m*/*z* = 826.95), indicating that the dinuclear species dominate in **6**; see [Figure S-8](http://pubs.acs.org/doi/suppl/10.1021/acsomega.7b01090/suppl_file/ao7b01090_si_001.pdf). For the Rh--*N*-acetylcysteine reaction product **7**, the majority of the mass peaks at 0 V were those of the tetranuclear Rh^III^~4~(NAC)~8--10~ species with an added O atom or H^+^/Na^+^ ions, with only a few peaks detected for the dinuclear Rh^III^~2~(NAC)~4~ species (see [Figure S-9 and Table S-3](http://pubs.acs.org/doi/suppl/10.1021/acsomega.7b01090/suppl_file/ao7b01090_si_001.pdf)).

The lowest fragmentor voltage that could generate mass peaks for the Rh--cysteine reaction product **5** was 10 V; however, no isotopic pattern could be observed ([Figure S-10 and Table S-4](http://pubs.acs.org/doi/suppl/10.1021/acsomega.7b01090/suppl_file/ao7b01090_si_001.pdf)). Similar to Rh--penicillamine **6**, peaks were assigned to the dinuclear species \[Rh^III^~2~(Cys)~4~ + H^+^\]^−^ (−*m*/*z* = 682.83), \[Rh^III^~2~(Cys)~4~ + H^+^ + O\]^−^ (−*m*/*z* = 698.83), and \[Rh^III^~2~(Cys)~4~ + H^+^ + 2O\]^−^ (−*m*/*z* = 714.81), assuming the charge −1. In addition, two less intense peaks were detected at (−)*m*/*z* = 803.84 and 819.85 for \[Rh^III^~2~(Cys)~5~ + 3H^+^\]^−^ and \[Rh^III^~2~(Cys)~5~ + 3H^+^ + O\]^−^ ions, respectively. Because the reaction of Rh~2~(AcO)~4~ with cysteine was carried out at the mole ratio 1:4, the presence of such a Rh/Cys 2:5 complex may indicate fragmentation of higher complexes, for example with a Rh/Cys 4:8 ratio, as observed in the ESI-mass spectrum measured at 80 V (see [Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}).

In summary, analyses of the ESI-mass spectra show formation of a dinuclear \[Rh^III^~2~(Pen)~4~\]^2--^ complex in **6**, dinuclear \[Rh^III^~2~(Cys)~4~\]^2--^ or tetranuclear {Rh^III^~2~(Cys)~4~^2--^}~2~ complexes in **5**, and oligomeric {Rh^III^~2~(NAC)~4~^2--^}~*n*~ species in **7** (with 1--2 added O atoms), and exclude formation of mononuclear Rh complexes.

### Sulfur K Edge XANES Spectroscopy {#sec3.1.2}

To examine whether the detected mass ions with 1--2 added O atoms correspond to sulfenato (S=O) or sulfinato (O=S=O) groups, S K edge XANES spectra of the Rh--cysteine (**5**), Rh--penicillamine (**6**), and Rh--*N*-acetylcysteine (**7**) solid reaction products were measured. The spectra and their corresponding smoothed second derivatives are shown in [Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}. There are four distinct absorption features for **6**, and only two absorption peaks at 2472.0 and ∼2474.0 eV for **5** and **7**.

![Sulfur K edge XANES spectra (left) and the corresponding smoothed second derivatives (right) of the solid products obtained from the reactions of Rh~2~(AcO)~4~ with cysteine (**5**), penicillamine (**6**), or *N*-acetylcysteine (**7**) at a mole ratio of 1:4 at pH = 7.4.](ao-2017-01090p_0003){#fig3}

In the spectrum of the nickel(II) cysteinate complex with 3d^8^ low-spin configuration and square-planar coordination, K~2~\[Ni(*S*,*N*-Cys)~2~\], the distinct pre-edge feature observed at 2471.1 eV and the main peak at 2472.8 eV correspond to S 1s transitions to an unoccupied frontier orbital with S 3p and Ni 3d*~xy~* character, and to a σ\*(C--S) orbital, respectively.^[@ref24]^ For the Rh--cysteine reaction product **5** with Rh(III) low-spin d^6^ configuration, it seems likely that the peaks at 2472.0 and 2474.0 eV correspond to the S(1s) → lowest unoccupied molecular orbital (LUMO) (with S(3p) and Rh(4d) character) and S(1s) → σ\*(C--S) transitions, respectively. The additional feature appearing in the spectrum of the Rh--penicillamine reaction product **6** at 2475.6 eV (less pronounced or absent for **5** or **7**) is probably due to a sulfenato (S=O) group bound to the Rh(III) ion, that is, a S~S=O~ (1s) → σ\* (C--S~S=O~) transition. The assignment is based on the peak at 2475.9 eV in the S XANES spectrum of methionine sulfoxide.^[@ref25]^ The low-energy shoulder at 2470.6 eV in the spectrum of **6** can then be tentatively assigned to S~S=O~ (1s) → LUMO (with S~S=O~ (3p) and Rh(4d) character).^[@ref24],[@ref26]^

### Rh K Edge EXAFS Spectroscopy {#sec3.1.3}

Because no single crystals could be prepared, we used Rh K edge X-ray absorption spectroscopy to determine the local structure, that is, nature/number of the nearest neighbors and bond distances, around the Rh(III) ions in the solid reaction products **5**--**7**. The *k*^3^-weighted Rh K edge EXAFS spectra and the corresponding Fourier transforms (FTs) for the solids **5**--**7** are shown in [Figure [4](#fig4){ref-type="fig"}](#fig4){ref-type="fig"} with the least-squares curve-fitting results presented in [Table [3](#tbl3){ref-type="other"}](#tbl3){ref-type="other"}. For comparison, EXAFS data for a concentrated solution of the related Rh--glutathione compound **8**, {Na~2~\[Rh^III^~2~(HA)~4~\]·7H~2~O}~*n*~ (H~3~A = glutathione), have also been included.^[@ref23]^ For all three H~2~L ligands, the EXAFS spectra collected from the solid Rh products (**5**--**7**) overlapped with those of the corresponding solution ([Figure S-11](http://pubs.acs.org/doi/suppl/10.1021/acsomega.7b01090/suppl_file/ao7b01090_si_001.pdf)), whereas the EXAFS spectra of **5**--**8** did not completely match ([Figure S-12](http://pubs.acs.org/doi/suppl/10.1021/acsomega.7b01090/suppl_file/ao7b01090_si_001.pdf)).

![*k*^3^-Weighted Rh K edge EXAFS spectra (left) and the corresponding Fourier transforms (right) of the solid products obtained from the reactions of Rh~2~(AcO)~4~ with cysteine (**5**), penicillamine (**6**), and *N*-acetylcysteine (**7**) at a mole ratio of 1:4 at pH = 7.4, compared to those of a concentrated solution of the dinuclear Rh-glutathione reaction product (**8**) (see [Table [3](#tbl3){ref-type="other"}](#tbl3){ref-type="other"}).](ao-2017-01090p_0004){#fig4}

###### Least-Squares Curve-Fitting Results for EXAFS Spectra of the Solid Reaction Products **5**--**7** and a Concentrated Solution of the Rh--Glutathione Reaction Product **8**[a](#t3fn2){ref-type="table-fn"},[b](#t3fn1){ref-type="table-fn"}

          Rh--(N/O)   Rh--S   Rh···Rh[c](#t3fn3){ref-type="table-fn"}                                                             
  ------- ----------- ------- ----------------------------------------- ----- ------- -------- ------ ---------- -------- ------- ------
  **5**   2.0         2.10    0.0037                                    4.1   2.34    0.0044   2.0    3.44       0.0142   0.7     14.7
  **6**   3.2         2.10    0.0039                                    3.2   2.315   0.0042   0.77   3.03 *f*   0.0078   --0.4   18.5
  **7**   2 *f*       2.09    0.0032                                    4.6   2.32    0.0050   0.80   3.10       0.0047   --0.2   17.5
  **8**   2.5         2.08    0.0034                                    4.1   2.33    0.0050   0.85   3.11       0.0046   1.2     17.6

See [Figure [4](#fig4){ref-type="fig"}](#fig4){ref-type="fig"}.

Amplitude reduction factor (*S*~0~^2^) = 0.92 fixed;^[@ref23]^*f* = fixed value; estimated errors: *R* ± 0.02 Å; σ^2^ ± 0.001 Å^2^; CN ± 10--15%.

Uncertain values for **5** and **6** (see text).

= fitting residual (%).

The curve-fitting results in *k*-space revealed that the mean Rh--(N/O) and Rh--S distances vary over a narrow range of 2.08--2.10 and 2.315--2.34 Å, respectively, with reasonable σ^2^ values (0.003--0.005 Å^2^). The Rh···Rh scattering path included in the fitting models for the Rh--*N*-acetylcysteine reaction product **7** resulted in the Rh···Rh distance 3.10 ± 0.02 Å (σ^2^ = 0.0047 ± 0.001 Å^2^), which is similar to that of the Rh--glutathione reaction product **8**.^[@ref23]^ For the Rh--cysteine (**5**) and Rh--penicillamine (**6**) reaction products, the introduction of a Rh···Rh scattering path to explain the small FT features at ∼3.0 and ∼2.8 Å, respectively, did not yield conclusive results for such a long and diffuse interaction (see [Table S-5](http://pubs.acs.org/doi/suppl/10.1021/acsomega.7b01090/suppl_file/ao7b01090_si_001.pdf)).

### ^13^C NMR Spectroscopy {#sec3.1.4}

To find out whether the carboxyl group in the thiol-containing ligands is bound to the Rh(III) ions, carbon-13 cross-polarization magic angle spinning (CPMAS) NMR spectra of the solids **4**--**7** were measured, and are compared with those of the pure ligands and Rh~2~(AcO)~4~ in [Figure [5](#fig5){ref-type="fig"}](#fig5){ref-type="fig"}. We previously assigned the peaks for 0.1 M alkaline solutions of these ligands (calibrated relative to the CH~3~OH signal at 49.15 ppm).^[@ref27]−[@ref29]^ The sets of doublets observed for solid [d]{.smallcaps}-penicillamine can be attributed to polymorphs, that is, two nonequivalent molecules in the crystal asymmetric unit,^[@ref30],[@ref31]^ although only the structure of crystalline racemic [dl]{.smallcaps}-penicillamine is known.^[@ref32]^ Similarly, the crystal structure has been reported for dihydrated Rh~2~(AcO)~4~,^[@ref33]^ but not for anhydrous Rh~2~(AcO)~4~. The broad peaks at δ~COO^--^~ = 191.7 and 193.3 ppm observed for Rh~2~(AcO)~4~ powder could be due to the presence of two different acetate groups, with O atoms of some acetate ligands in one molecule coordinated to the axial positions of another molecule, as in crystalline Rh~2~(CF~3~COO)~4~.^[@ref34],[@ref35]^

![Solid state ^13^C CPMAS NMR spectra obtained for Rh~2~(AcO)~4~ and its reaction products at a mole ratio of 1:4 with the ligands cysteine (**4**, pH = 3.2; **5**, pH = 7.4), penicillamine (**6**), and *N*-acetylcysteine (**7**), and for the pure solid ligands.](ao-2017-01090p_0005){#fig5}

The features in the ^13^C NMR spectra of the diamagnetic solids **4**--**7** are broad. However, an EPR spectrum of **7** showed only trace amounts of paramagnetic species, making this an unlikely cause of the broadness (see EPR Spectroscopy section in the [Supporting Information](http://pubs.acs.org/doi/suppl/10.1021/acsomega.7b01090/suppl_file/ao7b01090_si_001.pdf)).^[@ref36]^ Although only one set of broad ^13^C NMR features is observed for the *N*-acetylcysteinate compound **7**, there are two sets of NMR signals for **4**--**6**, probably due to two types of binding modes for the coordinated cysteinate and penicillaminate ligands. Also, different stereoisomers could lead to some splitting of the ^13^C NMR resonances into different sets, as for the \[Co^III^{Rh(*N*,*S*-Cys)~3~}~2~\]^3--^ complex with three possible isomers (ΔΔ, ΛΛ, ΔΛ) with slightly different chemical shifts.^[@ref37]^ However, the ^13^C NMR signals for **4**--**6** in [Figure [4](#fig4){ref-type="fig"}](#fig4){ref-type="fig"} are too broad to recognize separate stereoisomers.

The ^13^C NMR resonances associated with the carboxyl groups in the H~2~L ligands (173.6--175.4 ppm) are generally deshielded in the spectra of their Rh(III) compounds (**4**--**7**). For the Rh--penicillamine reaction product **6** there are two NMR resonances at 176.1 and 181.4 ppm, with the latter ∼7.3 ppm deshielded relative to that of the pure ligand (average ∼ 174.1 ppm). Also, for the Δ-*fac*-H~3~\[Rh(*N*,*S*-Cys)~3~\] complex crystallized from a HCl(aq) solution, the chemical shift δ~C~ = 181.0 ppm has been reported,^[@ref37]^ with the deshielding probably due to weak forces between −COO^--^ and the counter H^+^ ions.

Previously, we observed a similar shift of Δδ (^13^C) = 6.0 ppm for the carboxylate group in a Pb(II)--penicillamine solution (*C*~Pb(II)~ = 10 mM, *C*~H~2~Pen~ = 20 mM, pH = 9.6), which was then attributed to the tridentate coordination of a (*S*,*N*,*O*)-Pen^2--^ ligand to the Pb(II) ion.^[@ref27]^ Therefore, we assign the resonance at 181.4 ppm to a (*S*,*N*,*O*)-Pen^2--^ ligand bound to a Rh(III) ion in **6**. The other peak at 176.1 ppm is shifted only ∼2.0 ppm downfield relative to penicillamine, which indicates a penicillaminate ligand with a COO^--^ group that is not bound to Rh(III). The small shift could be due to ionic interactions of the COO^--^ group.

For the Rh--cysteine reaction product **4** that precipitated at pH = 3.2, there are three peaks in the carboxylate region at 174.0, 182.0, and 194.3 ppm. The latter peak was attributed to a protonated, noncoordinated carboxyl group (−COOH). This peak, which disappears in the Rh--cysteine reaction product **5** at pH = 7.4, is ∼1.0 ppm deshielded relative to that of Rh~2~(AcO)~4~ at δ~C~ = 193.3 ppm, and could not be related to unreacted dirhodium(II) tetraacetate. The peak at 182.0 ppm (182.3 ppm in **5**), which is shifted downfield by ∼8.4 ppm relative to that of cysteine (173.6 ppm), could again be related to a tridentate (*S*,*N*,*O*)-Cys^2--^ ligand bound to the Rh(III) ion. This peak has lower intensity relative to the corresponding resonance in the spectrum of the Rh--penicillamine reaction product **6** (181.4 ppm). The more intense peak at 174.0 ppm (176.3 ppm in **5**) is probably related to a cysteinate ligand with an uncoordinated COO^--^ group.

Discussion {#sec4}
==========

Aerobic Reaction of **1** with Penicillamine {#sec4.1}
--------------------------------------------

Within the first few hours after mixing the reagents Rh~2~(AcO)~4~ (**1**) and penicillamine at a mole ratio of 1:4 (initial pH 4.1), the species \[Rh~2~^II^(AcO)~4~(H~2~Pen)~1--2~\] ([Scheme [2](#sch2){ref-type="scheme"}](#sch2){ref-type="scheme"}a) and \[Rh~2~^II^(AcO)~3~(HPen)\] (+ or −H^+^) with a Rh~2~(II, II) core could be detected with ESI-MS. Oxidation of the rhodium ions was observed when two deprotonated penicillamine ligands were present, as in the \[Rh~2~^III^(AcO)~4~(HPen)~2~\] complex ([Scheme [2](#sch2){ref-type="scheme"}](#sch2){ref-type="scheme"}b). \[Rh~2~^III^(Pen)~4~\]^2--^ was detected within the first 10 min of reaction (see [Appendix 2](http://pubs.acs.org/doi/suppl/10.1021/acsomega.7b01090/suppl_file/ao7b01090_si_001.pdf) in the [Supporting Information](http://pubs.acs.org/doi/suppl/10.1021/acsomega.7b01090/suppl_file/ao7b01090_si_001.pdf)). The reaction occurs much faster at pH = 7.4.

![Proposed Pathway for Aerobic Reaction of Rh~2~(AcO)~4~ with Penicillamine: (a) \[Rh^II^~2~(AcO)~4~(H~2~Pen)\], (b) \[Rh^III^~2~(AcO)~4~(HPen)~2~\], (c) H~2~\[Rh^III^(Pen)~4~\], and Its Oxidized Form (d) H~2~\[Rh~2~(Pen)~2~(Pen(SO))~2~\], All Detected by ESI-MS at Acidic pH\
The reactions occur much faster at pH = 7.4, leading to compound **6**, Na~2~\[Rh~2~(Pen)~2~(Pen(SO))~2~\]·4.5H~2~O, with a structure similar to (d).](ao-2017-01090p_0007){#sch2}

The ESI-mass spectrum in the -- ion mode of the Rh--penicillamine compound Na~2~\[Rh~2~(Pen)~2~(Pen(SO))~2~\]·4.5H~2~O (**6**) dissolved in water was dominated by mass peaks for \[Rh^III^~2~Pen~4~ + H^+^\]^−^ (−*m*/*z* = 794.96) at fragmentor voltage = 0 V, and \[Rh^III^~2~Pen~4~ \]^2--^ (−*m*/*z* = 396.98) at 80 V, and their *m*/*z* +8 and +16 satellites. An absorption peak at 2475.6 eV in the S K edge XANES spectrum of **6** further revealed the presence of a sulfenato group (S=O) bound to Rh(III); see [Results](#sec3){ref-type="other"} section.

Oxidation of metal-bound thiolates by peroxides to sulfenato groups has been previously reported for thiolato Co(III)^[@ref38],[@ref39]^ and thiolato Ru(II) polypyridyl complexes,^[@ref40]^ as well as for glutathione-bound Ru(II)-arene and organo-Ir(III) anticancer compounds.^[@ref41]−[@ref43]^ Liu and Sadler proposed that hydrogen peroxide (detected by a H~2~O~2~ test stick), formed from O~2~(g), provides the sulfenato (S=O) oxygen atom,^[@ref42]^ as previously suggested by the Dunbar group.^[@ref15]^ Here, we also propose that oxidation of the Rh~2~^4+^ core in **1** to Rh~2~^6+^ in **6** occurs by reduction of oxygen (O~2~) to peroxide ([eq [1](#eq1){ref-type="disp-formula"}](#eq1){ref-type="disp-formula"}), which in turn may oxidize a coordinated penicillamine thiolato to a sulfenato (S=O) group ([eq [2](#eq2){ref-type="disp-formula"}](#eq2){ref-type="disp-formula"}). Formation of peroxide in the reaction mixture was confirmed by an iodine test (see [Appendix 1](http://pubs.acs.org/doi/suppl/10.1021/acsomega.7b01090/suppl_file/ao7b01090_si_001.pdf) in the [Supporting Information](http://pubs.acs.org/doi/suppl/10.1021/acsomega.7b01090/suppl_file/ao7b01090_si_001.pdf)).^[@ref44]^The structure of the Rh--penicillamine compound **6** was probed by Rh K edge EXAFS, complemented by ^13^C CPMAS NMR spectroscopy, which revealed 3.1 Rh--(N/O) and 3.2 Rh--S distances at 2.09 ± 0.02 and 2.32 ± 0.02 Å, respectively ([Figure [4](#fig4){ref-type="fig"}](#fig4){ref-type="fig"} and [Table [3](#tbl3){ref-type="other"}](#tbl3){ref-type="other"}). The observation of two ^13^C NMR signals at 181.4 and 176.1 ppm for this solid ([Figure [5](#fig5){ref-type="fig"}](#fig5){ref-type="fig"}) provides evidence for two types of carboxylate groups, and thus supports two coordination modes for the Rh(III)-bound penicillamine ligands: tridentate (*S*,*N*,*O*-Pen) and bidentate (*S*,*N*-Pen); see [Results](#sec3){ref-type="other"} section. Compound **6** is expected to have a similar structure as that shown in [Scheme [2](#sch2){ref-type="scheme"}](#sch2){ref-type="scheme"}d.

[Scheme [2](#sch2){ref-type="scheme"}](#sch2){ref-type="scheme"} displays our proposed pathway for the aerobic reaction between Rh~2~(AcO)~4~ and penicillamine (mole ratio of 1:4). In the proposed structure for Na~2~\[Rh~2~(Pen)~2~(Pen(SO))~2~\]·4.5H~2~O (**6**), the O atom is bound to the S atom of a tridentate (*S*,*N*,*O*-Pen) ligand because in Rh--S--C, the S atom, with bonds to two other atoms, is sterically less hindered for nucleophilic attack by peroxide than the bridging S atom in Rh--S~bridge~--Rh with three bonds ([Scheme [2](#sch2){ref-type="scheme"}](#sch2){ref-type="scheme"}).^[@ref38],[@ref39]^

In our CSD survey, only three crystalline dithiolato-bridged binuclear Rh(III) complexes were found, for which the average Rh···Rh distance is 3.54 ± 0.03 Å (see [Table S-6](http://pubs.acs.org/doi/suppl/10.1021/acsomega.7b01090/suppl_file/ao7b01090_si_001.pdf)a--c in the [Supporting Information](http://pubs.acs.org/doi/suppl/10.1021/acsomega.7b01090/suppl_file/ao7b01090_si_001.pdf)). In the binuclear \[Rh^III^(μ-*S*,*N*-C~6~H~6~NS)(η^1^-*S*-C~6~H~6~NS)(bpy)\]~2~^2+^ complex with a similar (S,N)-donor ligand as that in the Rh--penicillamine compound **6**, the Rh···Rh distance is 3.51(3) Å.^[@ref14]^ The contribution of Rh···Rh scattering to the overall Rh K edge EXAFS spectrum of **6** would be insignificant for a long nonbonded distance (with high σ^2^), and does not appear as a well-resolved peak in the EXAFS Fourier transform in [Figure [4](#fig4){ref-type="fig"}](#fig4){ref-type="fig"}.

Aerobic Reaction of **1** with Cysteine {#sec4.2}
---------------------------------------

The aerobic reaction of Rh~2~(AcO)~4~ with cysteine at a mole ratio of 1:4 differs from that with penicillamine. The diamagnetic precipitate gradually formed at pH = 3.2 was separated and analyzed with the empirical formula {Rh~2~^III^(HCys)~2~(Cys)~2~·4H~2~O}~*n*~ (**4**). When raising the pH of the reaction mixture, the precipitate dissolved completely at pH = 3.9. The solid product obtained after initially adjusting the pH of the reaction mixture to 7.4 (see [Experimental Section](#sec2){ref-type="other"}) empirically corresponds to the formula {Na~2~\[Rh^III^~2~(Cys)~4~\]·5H~2~O}~*n*~ (**5**).

The Rh K edge EXAFS spectrum of this solid was identical to that of **4** ([Figure S-13](http://pubs.acs.org/doi/suppl/10.1021/acsomega.7b01090/suppl_file/ao7b01090_si_001.pdf)), but had a different phase and amplitude when compared with that of the Rh--penicillamine compound **6** (see [Figure S-12](http://pubs.acs.org/doi/suppl/10.1021/acsomega.7b01090/suppl_file/ao7b01090_si_001.pdf), top). Least-squares curve-fitting of the EXAFS oscillation for the solid **5** revealed contributions from 2.0 Rh--(N/O) and 4.1 Rh--S bond distances at 2.10 ± 0.02 and 2.34 ± 0.02 Å, respectively (see [Figure [4](#fig4){ref-type="fig"}](#fig4){ref-type="fig"} and [Table [3](#tbl3){ref-type="other"}](#tbl3){ref-type="other"}).

The ^13^C CPMAS NMR spectrum of the solid **5** displays a main peak at 176.3 ppm and a shoulder at 182.3 ppm ([Figure [5](#fig5){ref-type="fig"}](#fig5){ref-type="fig"}) assigned to bidentate (*S*,*N*-Cys) and tridentate (*S*,*N*,*O*-Cys), respectively (see [Results](#sec3){ref-type="other"} section). The different relative intensity of these two peaks, as compared with the ^13^C NMR spectrum of the Rh--penicillamine compound Na~2~\[Rh~2~(Pen)~2~(Pen(SO))~2~\]·4.5H~2~O (**6**), implies that the bidentate (S,N)-mode of the cysteinate ligands in **5** dominates.

The weak absorption at 2475.6 eV in the S K edge XANES spectrum of the Rh--cysteine compound **5** shows a significantly smaller amount of sulfenato (S=O) groups than that in **6** ([Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}). However, in the ESI-mass spectrum of **5** (dissolved in water), the *m*/*z* +8 and +16 satellites for the peaks at (−)*m*/*z* = 340.91 and 682.83 correspond to one or two additional oxygen atoms to the \[Rh~2~(Cys)~4~\]^2--^ and \[Rh~2~(Cys)~4~ + H^+^\]^−^ mass ions ([Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"} and [Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}), respectively, indicating that ESI-MS is a more sensitive probe for detecting small amounts of additional O atoms. Even at the low fragmentor voltage of 10 V, intense *m*/*z* +8 and/or 16 peaks were identified for the mass ions \[Rh~2~(Cys)~4~ + H^+^\]^−^ (−*m*/*z* = 682.83) and \[Rh~2~(Cys)~5~ + 3H^+^\]^−^ (−*m*/*z* = 803.84); see [Figure S-10 and Table S-4](http://pubs.acs.org/doi/suppl/10.1021/acsomega.7b01090/suppl_file/ao7b01090_si_001.pdf). It is unlikely that the added O atoms are generated from oxidation in the ESI-MS instrument because, for example, no *m*/*z* +8 and/or 16 satellites were observed for \[Rh^III^~2~(AcO)~4~(HNAC)~2~ + Na^+^\]^+^ (+*m*/*z* = 788.90) or *N*-acetylcysteine \[H~2~NAC -- H^+^\]^−^ (−*m*/*z* = 162.02) in [Figures S-2 and S-6](http://pubs.acs.org/doi/suppl/10.1021/acsomega.7b01090/suppl_file/ao7b01090_si_001.pdf), respectively.

At the fragmentor voltage of 80 V, additional mass peaks corresponding to tri- and tetranuclear species appeared, such as: \[Rh~3~(Cys)~6~\]^3--^ (−*m*/*z* = 340.91), \[Rh~3~(Cys)~6~ + H^+^\]^2--^ (−*m*/*z* = 511.87), \[Rh~3~(Cys)~6~ + H^+^ + O\]^2--^ (−*m*/*z* = 519.87), \[Rh~4~(Cys)~8~ + H^+^\]^3--^ (−*m*/*z* = 454.89), and \[Rh~4~(Cys)~8~ + 2H^+^ + O\]^2--^ (−*m*/*z* = 690.83). The ESI-MS analysis of the Rh--penicillamine reaction product **6** also shows minor amounts of similar tetramers {Na~2~\[Rh~2~(Pen)~4~\]}~*n*~ (*n* = 2), based on the isotopic patterns of the peaks (−)*m*/*z* = 794.96 and 810.95 for the \[Rh~4~(Pen)~8~ + 2H^+^\]^2--^ and \[Rh~4~(Pen)~8~ + 2H^+^ + O\]^2--^ ions, respectively (see [Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}). Although some cluster formation could also be observed in the ESI-mass spectra of pure Rh~2~(AcO)~4~ in water ([Figure S-6](http://pubs.acs.org/doi/suppl/10.1021/acsomega.7b01090/suppl_file/ao7b01090_si_001.pdf)), the difference between the EXAFS spectra of **5** and **6** ([Figure S-12](http://pubs.acs.org/doi/suppl/10.1021/acsomega.7b01090/suppl_file/ao7b01090_si_001.pdf)) can only be explained by the presence of oligomeric species in **5**.

On the basis of the combined results, we conclude that in the reaction product **5** of Rh~2~(AcO)~4~ and cysteine (pH = 7.4), the Rh(III) ions are connected via double thiolate bridges probably in at least up to tetrameric species, although some dimeric Na~2~\[Rh~2~(Cys)~4~\] complexes, similar to those found for the Rh--penicillamine compound **6**, cannot be ruled out. [Scheme [3](#sch3){ref-type="scheme"}](#sch3){ref-type="scheme"} displays our proposed structure for a tetramer {Na~2~\[Rh~2~(Cys)~4~\]}~*n*~ (*n* = 2) and its oxidized form, as identified by ESI-MS.

![Proposed Structures for a Tetrameric {Na~2~\[Rh~2~(Cys)~4~\]}~2~ Complex in Compound **5**\
The lower image is its oxidized form, detected by ESI-MS, with sulfenato (S=O) groups.](ao-2017-01090p_0008){#sch3}

In a large oligomeric structure for **5**, there are four Rh--S and two Rh--(N/O) bonds around the Rh(III) ions (except for the terminal units), as indicated by the EXAFS data analysis ([Table [3](#tbl3){ref-type="other"}](#tbl3){ref-type="other"}). Only the S atoms with two bonds in the terminal tridentate (*S*,*N*,*O*-Cys) ligands are expected to be oxidized by peroxide to sulfenato (S=O) groups because the bridging thiolate groups with three bonds are less susceptible to nucleophilic attack by peroxide.^[@ref38]^ The number of unbound COO^--^ groups is considerably higher than that of the bound terminal COO^--^, which gives rise to a small shoulder at δ = 182.3 ppm in the ^13^C CPMAS NMR spectrum of **5** ([Figure [5](#fig5){ref-type="fig"}](#fig5){ref-type="fig"}). The close overlap of the EXAFS spectra ([Figure S-13](http://pubs.acs.org/doi/suppl/10.1021/acsomega.7b01090/suppl_file/ao7b01090_si_001.pdf)) indicates that the structures of the Rh--cysteine precipitate **4**, {Rh~2~(Cys)~2~(HCys)~2~·4H~2~O}~*n*~ from acidic (pH = 3.2) media, and **5** are similar, apart from the protonated −COOH groups in **4**, shown by the ^13^C NMR resonance at δ = 194.3 ppm ([Figure [5](#fig5){ref-type="fig"}](#fig5){ref-type="fig"}).

The chiral \[Rh(*S*,*N*-Cys)~3~\]^3--^ complex readily functions as a S-donating ligand to form linear S-bridged trinuclear \[M{Rh(*S*,*N*-Cys)~3~}~2~\]^3--/4--^ complexes with various metal ions (M = Cr^III^, Co^II or III^, and Ni^II^) with MS~6~ coordination,^[@ref37],[@ref45],[@ref46]^ as well as in the T-cage S-bridged polynuclear complex \[{Rh(*S*,*N*-Cys)~3~}~4~Zn~4~O\]^6--^, which has been studied for decades.^[@ref47]^ Polynuclear S-bridged structures such as the tetranuclear one proposed in [Scheme [3](#sch3){ref-type="scheme"}](#sch3){ref-type="scheme"} for the {\[Rh^III^~2~(*S*,*N*-Cys)~4~\]^2--^}~*n*~ (*n* = 2) complex are other examples of this type of multinuclear compound, formed in absence of a different metal ion (M).

Such oligomers could be formed with morphologically similar but not identical Rh(III) centers, for example, with different orientations/conformations of Cys^2--^ or Pen^2--^ rings. The variations in the local environment of the carbon atoms in these ligands would result in broad signals in the ^13^C NMR spectra in [Figure [5](#fig5){ref-type="fig"}](#fig5){ref-type="fig"}.^[@ref48]−[@ref52]^ Recently, a ^1^H NMR spectrum was reported for a D~2~O solution of *S*-methylcysteine coordinated to the axial position of Rh~2~(AcO)~4~ (mole ratio of 1:1); the broad signals observed in this spectrum were attributed to *J*(H,H) coupling.^[@ref53]^

Aerobic Reaction of **1** with *N*-Acetylcysteine {#sec4.3}
-------------------------------------------------

Monitoring the slow reaction of Rh~2~(AcO)~4~ (**1**) with *N*-acetylcysteine (mole ratio of 1:4) at the pH of mixing (pH = 1.9) with ESI-MS revealed that species with one *N*-acetylcysteine ligand (in protonated or even fully deprotonated form) still keep the Rh^II^--Rh^II^ core, as in \[Rh^II^~2~(AcO)~4~(H~2~NAC)\] and \[Rh^II^~2~(AcO)~3~(HNAC)\] (with ±H^+^ or +Na^+^) as well as \[Rh^II^~2~(AcO)~2~(NAC)\]. Similar to the penicillamine reaction, oxidation to Rh(III) is observed in species with two deprotonated *N*-acetylcysteine ligands: \[Rh^III^~2~(AcO)~4~(HNAC)~2~\] and \[Rh^III^~2~(AcO)~3~(HNAC)~2~\]^+^ (see [Appendix 1](http://pubs.acs.org/doi/suppl/10.1021/acsomega.7b01090/suppl_file/ao7b01090_si_001.pdf) in the [Supporting Information](http://pubs.acs.org/doi/suppl/10.1021/acsomega.7b01090/suppl_file/ao7b01090_si_001.pdf)).

Following the reaction in acidic solution with UV--vis spectroscopy showed after 48 h, an intense absorption peak at λ~max~ = 367 nm ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}, left), which is attributed to a S^--^ → Rh^III^ ligand-to-metal charge-transfer band of the \[Rh^III^~2~(AcO)~4~(HNAC)~2~\] complex, which is the main Rh(III) complex according to the ESI-mass spectrum (+*m*/*z* = 766.91, 788.90, and 810.88 for +H^+^/Na^+^ ions, [Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"} and [Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"} right). The EXAFS spectrum of this complex could not be obtained due to the presence of unreacted Rh~2~(AcO)~4~ (see ^1^H NMR and ESI-mass spectra in [Appendix 1](http://pubs.acs.org/doi/suppl/10.1021/acsomega.7b01090/suppl_file/ao7b01090_si_001.pdf)).

The solid reaction product at pH = 7.4, purified by size exclusion chromatography, has the empirical formula {Na~2~\[Rh~2~(NAC)~4~\]·4.5H~2~O}~*n*~ (**7**), based on elemental analysis. The Rh K edge EXAFS spectra of **7** and of the corresponding Rh--cysteine reaction product **5** show main FT peaks of similar magnitude, but with an additional feature at ∼2.7 Å for **7**, as also found for the Rh--glutathione reaction product **8** ([Figure S-12](http://pubs.acs.org/doi/suppl/10.1021/acsomega.7b01090/suppl_file/ao7b01090_si_001.pdf)).^[@ref23]^ Its EXAFS oscillation was best modeled with 2 Rh--O, 4.6 Rh--S, and 0.8 Rh···Rh interactions at mean distances of 2.09 ± 0.02, 2.32 ± 0.02, and 3.10 ± 0.02 Å, respectively, which are similar to those obtained for **8** (see [Figure [4](#fig4){ref-type="fig"}](#fig4){ref-type="fig"} and [Table [3](#tbl3){ref-type="other"}](#tbl3){ref-type="other"}). The Rh--O scattering contribution is better resolved for **8**, appearing as a shoulder in the main FT peak, probably due to less noise in its EXAFS oscillation. Simultaneous refinement of the Rh--O coordination number for **7** resulted in an unreasonably high value (5.7) for the Rh--S coordination number, and very small σ^2^ for Rh--O (see [Table S-5](http://pubs.acs.org/doi/suppl/10.1021/acsomega.7b01090/suppl_file/ao7b01090_si_001.pdf)). In the trimeric ΔΛ-\[Rh{Ir(aet)~3~}~2~\]^3+^ complex (CSD code: AQUVOX), the central Rh(III) ion is surrounded by six bridging thiolate groups with the average Rh--S distance 2.381 Å,^[@ref19]^ which is longer than the refined mean Rh--S distance in **7**. Therefore, a model including two Rh--O and four Rh--S scattering paths seems reasonable. The Rh^III^···Rh^III^ distance in **7** is comparable with the Rh^III^···Ir^III^ distance of 3.0199(3) Å in the \[Rh{Ir(aet)~3~}~2~\]^3+^ complex with three bridging thiolate groups between the Rh(III) and Ir(III) ions in N~3~Ir(μ-S)~3~Rh(μ-S)~3~IrN~3~ coordination.^[@ref19]^

The ^13^C CPMAS NMR spectrum of **7** only shows one set of broad peaks for the coordinated *N*-acetylcysteine, with the COO^--^ group resonating at δ = 177.1 ppm, shifted downfield only by Δδ (^13^C) = 1.7 ppm relative to that of the pure ligand ([Figure [5](#fig5){ref-type="fig"}](#fig5){ref-type="fig"}), indicating that the carboxylate group is not directly bonded to the Rh(III) atoms in **7**. The ESI-mass spectrum of this product in water at fragmentor voltage 0 V was dominated by mass peaks for tetranuclear Rh^III^~4~(NAC)~8--10~ (*m*/*z* = 850.87, 932.39, and 1024.88) or dinuclear Rh^III^~2~(NAC)~4~ species, and their *m*/*z* +8 satellites for one added O atom (see [Figure S-9 and Table S-3](http://pubs.acs.org/doi/suppl/10.1021/acsomega.7b01090/suppl_file/ao7b01090_si_001.pdf)).

The EXAFS results show that {Na~2~\[Rh~2~(NAC)~4~\]·4.5H~2~O}~*n*~ (**7**) contains triply S-bridged Rh^III^···Rh^III^ units with a well-defined distance of 3.10 ± 0.02 Å that gives rise to an extended EXAFS oscillation ([Figure [4](#fig4){ref-type="fig"}](#fig4){ref-type="fig"}). A single or double thiolate bridge connecting those dimeric units into an oligomeric structure, as proposed in [Scheme [4](#sch4){ref-type="scheme"}](#sch4){ref-type="scheme"}, would be consistent with the refined coordination number of 4.6 for the Rh--S scattering path. The scattering contribution from Rh(III) ions bridged by one or two thiolate groups (as in compound **5**) at Rh···Rh distances \>3.5 Å would be damped in the EXAFS oscillation.

![Proposed Oligomeric Structures for the {Na~2~\[Rh~2~(NAC)~4~\]·4.5H~2~O}~*n*~ (Compound **7**)](ao-2017-01090p_0009){#sch4}

An oligomeric structure for **7** would justify the Rh~4~(NAC)~8--10~ and Rh~6~(NAC)~10--12~ mass ions in the ESI-MS spectra ([Tables [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"} and [S-3](http://pubs.acs.org/doi/suppl/10.1021/acsomega.7b01090/suppl_file/ao7b01090_si_001.pdf)). In such an oligomeric structure, only the terminal thiolate can be oxidized by peroxide to a sulfenato group. In the ESI-mass spectrum of **7**, just one added O atom was observed as an *m*/*z* +8 satellite for the dimeric (−*m*/*z* = 866.87) or tetrameric (−*m*/*z* = 858.87) Rh--*N*-acetylcysteine species (see [Tables [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"} and [S-5](http://pubs.acs.org/doi/suppl/10.1021/acsomega.7b01090/suppl_file/ao7b01090_si_001.pdf)), indicating that there are more bridging than terminal thiolate groups.

Conclusions {#sec5}
===========

Aerobic reactions of Rh~2~(AcO)~4~ with the thiol-containing amino acid cysteine (H~2~Cys) and its derivatives penicillamine (H~2~Pen) and *N*-acetylcysteine (H~2~NAC) in different mole ratios (1:2, 1:4, and 1:6) at pH = 7.4 result in the formation of the diamagnetic compounds {Na~2~\[Rh^III^~2~L~4~\]·*x*H~2~O}~*n*~ (L = Cys and NAC; *x* = 4.5--5) and Na~2~\[Rh^III^~2~(Pen)~2~(Pen(SO))~2~\]·4.5H~2~O. The complexes were structurally characterized by combining the results from Rh K edge EXAFS, S K edge XANES, and solid state ^13^C CPMAS NMR spectroscopic techniques. In the binuclear penicillamine complex, the thiolate groups of two (*S*,*N*-Pen) ligands bridge the Rh(III) ions and the other two terminal ligands bind in tridentate mode (*S*,*N*,*O*-Pen); the bond to the COO^--^ group was evidenced by a change of chemical shift Δδ~C~ = 7.3 ppm relative to that of the pure ligand. Oxidation of Rh~2~^4+^ to Rh~2~^6+^ occurs through oxygen (O~2~) that is reduced to peroxide, which in turn can partially oxidize terminal thiolate (S--Rh^III^) to sulfenato (O=S--Rh^III^) groups. The presence of sulfenato groups in Na~2~\[Rh^III^~2~(Pen)~2~(Pen(SO))~2~\]·4.5H~2~O was confirmed by a peak at 2475.6 eV in its S K edge XANES spectrum.

The high Rh--S coordination number obtained from the EXAFS data analysis of the compound {Na~2~\[Rh^III^~2~(Cys)~4~\]·5H~2~O}~*n*~ is consistent with oligomeric species in which dithiolate bridges of chelating (*S*,*N*-Cys) ligands connect the Rh(III) ions. In comparison with the dimeric penicillamine complex, there are fewer terminal tridentate (*S*,*N*,*O*-Cys) ligands that can then be oxidized to sulfenato groups (O=S--Rh^III^), which could only be detected by ESI-MS.

In the compound {Na~2~\[Rh^III^~2~(NAC)~4~\]·4.5H~2~O}~*n*~, *N*-acetylcysteine behaves similarly to glutathione and acts as a monodentate S-donor ligand, forming a triple (*S*-NAC) bridge between two Rh(III) ions with a well-defined Rh···Rh distance of 3.10 ± 0.02 Å, according to the Rh K edge EXAFS data analysis. Those dimeric units are probably linked together into oligomeric complexes by single or double thiolate bridges. The bridging thiolate groups, sterically hindered by bonds to three atoms, are not oxidized by peroxide, leaving only the terminal thiolates (S--Rh^III^) exposed to oxidation to sulfenato groups.

The results of this study reveal the structure of products that could form when antitumor active rhodium(II) tetraacetate, Rh~2~(AcO)~4~, interacts with thiol-containing proteins and peptides, whether acting like *N*-acetylcysteine or glutathione as a monothiolate entity, or as the (S,N-) chelate cysteine in an N-terminal site of a protein.

The Supporting Information is available free of charge on the [ACS Publications website](http://pubs.acs.org) at DOI: [10.1021/acsomega.7b01090](http://pubs.acs.org/doi/abs/10.1021/acsomega.7b01090).^1^H NMR spectra of the reaction mixture containing Rh~2~(AcO)~4~ (**1**) and *N*-acetylcysteine (1:4 mole ratio, *C*~**1**~ = 4.5 mM, pD = 2.3); ESI-mass spectra of pure Rh~2~(AcO)~4~ and pure *N*-acetylcysteine in water, of the reaction mixture containing Rh~2~(AcO)~4~ and *N*-acetylcysteine (mole ratio 1:4, *C*~**1**~ = 1 and 4.5 mM, acidic pH), and of the reaction mixture of Rh~2~(AcO)~4~ and penicillamine (mole ratio 1:4, *C*~**1**~ = 1.9 mM, acidic pH), and assignment of the corresponding mass peaks; UV--vis spectra of the latter solution and the reaction mixture containing Rh~2~(AcO)~4~ and *N*-acetylcysteine (mole ratio 1:4, *C*~**1**~ = 1.0 mM, pH = 7.4) at different time intervals; fragmentor voltage varied ESI-mass spectra of Na~2~\[Rh~2~(Pen)~2~(Pen(SO))~2~\]·4.5H~2~O (**6**), {Na~2~\[Rh^III^~2~(Cys)~4~\]·5H~2~O}~*n*~ (**5**), and {Na~2~\[Rh~2~(NAC)~4~\]·4.5H~2~O}~*n*~ (**7**); UV--vis spectra of aqueous solutions of **6** and **7**; comparison between the *k*^3^-weighted EXAFS spectra of the concentrated aqueous solutions and their corresponding solid products **5**--**7** and those of solids {Rh^III^~2~(HCys)~2~(Cys)~2~·4H~2~O}~*n*~ (**4**) and **5**; comparison between the *k*^3^-weighted EXAFS spectra of the solid products **5**--**7** and the Rh--glutathione complex **8**; comparison between the first derivative EPR spectra of Cu(ClO~4~)~2~·6H~2~O and solid 7; comparison between the yields of reaction products **5**--**7** when using different Rh~2~(AcO)~4~/H~2~L mole ratios at pH = 7.4, and ESI-mass spectra for the Rh~2~(AcO)~4~/H~2~Pen reaction mixture (mole ratio 1:2, pH = 7.4) ([PDF](http://pubs.acs.org/doi/suppl/10.1021/acsomega.7b01090/suppl_file/ao7b01090_si_001.pdf))
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